3-(3-fluoro-4-methylphenyl)propan-1-ol | 1036395-91-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(3-fluoro-4-methylphenyl)propan-1-ol
• CAS: 1036395-91-1
• 化学式: C₁₀H₁₃FO
• 分子量: 168.211
• InChiKey: KVUQVGMVFMSRPL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(3-fluoro-4-methylphenyl)propan-1-ol 在 咪唑 、 碘 、 三苯基膦 作用下， 生成 2-Fluoro-4-(3-iodo-propyl)-1-methyl-benzene
  参考文献：
  名称：

  Design, synthesis and cytotoxicity of 7-deoxy aryl discodermolide analogues

  摘要：

  A series of 7-deoxy discodermolide analogues in which the lactone fragment 'C' was replaced by aryl substituents were designed, synthesized, and evaluated for cytotoxicity. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.01.102
• 作为产物：
  描述：

  magnesium,1-fluoro-2-methylbenzene-5-ide,bromide 在 9-borabicyclo[3.3.1]nonane dimer 作用下， 生成 3-(3-fluoro-4-methylphenyl)propan-1-ol
  参考文献：
  名称：

  Design, synthesis and cytotoxicity of 7-deoxy aryl discodermolide analogues

  摘要：

  A series of 7-deoxy discodermolide analogues in which the lactone fragment 'C' was replaced by aryl substituents were designed, synthesized, and evaluated for cytotoxicity. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.01.102

文献信息

• Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M1 – M5 muscarinic acetylcholine receptors
  作者：Na-Ra Lee、Satheesh Gujarathi、Shobanbabu Bommagani、Kiranbabu Siripurapu、Guangrong Zheng、Linda P. Dwoskin

  DOI：10.1016/j.bmcl.2018.12.022

  日期：2019.2

  analogs were synthesized, and binding affinities at M1-M5 muscarinic acetylcholine receptor (mAChR) subtypes were determined using Chinese hamster ovary (CHO) cell membranes stably expressing one specific subtype of human mAChR. Although not subtype selective, the lead analog (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate (3c) exhibited the highest affinity (Ki = 2.0, 13, 2.6, 2.2, 1.8 nM) at

  合成了新型奎宁环基 N-苯基氨基甲酸酯类似物，并使用稳定表达人 mAChR 一种特定亚型的中国仓鼠卵巢 (CHO) 细胞膜测定了 M1-M5 毒蕈碱乙酰胆碱受体 (mAChR) 亚型的结合亲和力。尽管不具有亚型选择性，但先导类似物 (±)-奎宁环素-3-基-(4-氟苯乙基)(苯基)氨基甲酸酯 (3c) 在每个位置均表现出最高的亲和力 (Ki = 2.0, 13, 2.6, 2.2, 1.8 nM)分别是M1-M5 mAChR。根据使用大鼠纹状体切片的[3H]多巴胺释放测定的结果，3c充当mAChRs的激动剂。3c 的作用被非选择性 mAChR 拮抗剂东莨菪碱和氧化震颤素引起的 3c 增强释放所抑制。来自同一支架的有效类似物 (±)-奎宁环素-3-基-(4-甲氧基苯乙基)(苯基)-氨基甲酸酯 (3b) 对 M3 表现出比 M2 mAChR 最大的选择性（17 倍）。这些类似物可以作为进一步发
• 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES
  申请人：Aissaoui Hamed

  公开号：US20100093740A1

  公开（公告）日：2010-04-15

  The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I), wherein X represents CH 2 or O; R 1 represents a phenyl group, which group is independently mono-, di-, or tri-substituted wherein the substituents are independently selected from the group consisting of (C 1-4 )alkyl, (C 1-4 )alkoxy, halogen, cyano, trifluoromethoxy and trifluoromethyl; R 2 represents (C 1-4 )alkyl, (C 1-4 )alkoxy, (C 2-4 )alkenyl, halogen, cyano, hydroxymethyl, trifluoromethyl, C(O)NR 5 R 6 or cyclopropyl; R 3 represents (C 1-4 )alkyl, (C 1-4 )alkoxy-methyl or halogen; R 4 represents (C 1-4 )alkyl; R 5 represents hydrogen or (C 1-4 )alkyl; and R 6 represents hydrogen or (C 1-4 )alkyl. The invention also relates to pharmaceutically acceptable salts of such compounds; and to the use of such compounds as medicaments; especially as orexin receptor antagonists.

  本发明涉及公式（I）的5,6,7,8-四氢咪唑[1,5-a]吡嗪衍生物，其中X代表CH2或O; R1代表苯基，该基团独立地单取代、双取代或三取代，其中取代基独立地选自由（C1-4）烷基，（C1-4）烷氧基，卤素，氰基，三氟甲氧基和三氟甲基的群组; R2代表（C1-4）烷基，（C1-4）烷氧基，（C2-4）烯基，卤素，氰基，羟甲基，三氟甲基，C（O）NR5R6或环丙基; R3代表（C1-4）烷基，（C1-4）烷氧甲基或卤素; R4代表（C1-4）烷基; R5代表氢或（C1-4）烷基; R6代表氢或（C1-4）烷基。本发明还涉及这种化合物的药学上可接受的盐;以及将这种化合物用作药物的用途;特别是作为促进睡眠激素受体拮抗剂。
• US8188082B2
  申请人：——

  公开号：US8188082B2

  公开（公告）日：2012-05-29
• [EN] 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES<br/>[FR] DÉRIVÉS DE 5,6,7,8-TÉTRAHYDRO-IMIDAZO[1,5-A]PYRAZINE
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2008078291A1

  公开（公告）日：2008-07-03

  [EN] The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I),wherein X represents CH₂ or O; R¹ represents a phenyl group, which group is independently mono-, di-, or tri-substituted wherein the substituents are independently selected from the group consisting of (C_1-4)alkyl, (C_1-4)alkoxy, halogen, cyano, trifluoromethoxy and trifluoromethyl; R² represents (C_1-4)alkyl, (C_1-4)alkoxy, (C_2-4)alkenyl, halogen, cyano, hydroxymethyl, trifluoromethyl, C(O)NR⁵R⁶ or cyclopropyl; R³ represents (C_1-4)alkyl, (C_1-4)alkoxy-methyl or halogen; R⁴ represents (C_1-4)alkyl; R⁵ represents hydrogen or (C_1-4)alkyl; and R⁶ represents hydrogen or (C_1-4)alkyl. The invention also relates to pharmaceutically acceptable salts of such compounds; and to the use of such compounds as medicaments; especially as orexin receptor antagonists.
  [FR] L'invention porte sur des dérivés de 5,6,7,8-tétrahydro-imidazo[1,5-a]pyrazine de formule (1), dans laquelle X représente CH₂ ou O ; R¹ représente un groupe phényle, lequel groupe est indépendamment mono-, di- ou tri- substitué, les substituants étant indépendamment choisis dans le groupe constitué par alkyle en C₁-C₄, alcoxy en C₁-C₄, halogène, cyano, trifluorométhoxy et trifluorométhyle ; R² représente alkyle en C₁-C₄, alcoxy en C₁-C₄, alcényle en C_2-C₄, halogène, cyano, hydroxyméthyle, trifluorométhyle, C(O)NR⁵R⁶ou cyclopropyle ; R³ représente alkyle en C₁-C₄, alcoxy en C_1-C₄-méthyle, ou halogène ; R⁴représente alkyle en C₁-C₄ ; R⁵ représente hydrogène ou alkyle en C₁-C₄ ; et R⁶ représente hydrogène ou alkyle en C₁-C₄. L'invention porte également sur des sels pharmaceutiquement acceptables de tels composés ; et sur l'utilisation de tels composés en tant que médicaments, notamment en tant qu'antagonistes du récepteur de l'orexine.
• Design, synthesis and cytotoxicity of 7-deoxy aryl discodermolide analogues
  作者：Mark A Burlingame、Simon J Shaw、Kurt F Sundermann、Dan Zhang、Joseph Petryka、Esteban Mendoza、Fenghua Liu、David C Myles、Matthew J LaMarche、Tomoyasu Hirose、B Scott Freeze、Amos B Smith

  DOI：10.1016/j.bmcl.2004.01.102

  日期：2004.5

  A series of 7-deoxy discodermolide analogues in which the lactone fragment 'C' was replaced by aryl substituents were designed, synthesized, and evaluated for cytotoxicity. (C) 2004 Elsevier Ltd. All rights reserved.